GPR55 receptor antagonist decreases glycolytic activity in PANC ‐1 pancreatic cancer cell line and tumor xenografts

This article is protected by copyright. All rights reserved. (Source: International Journal of Cancer)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2vVCrgi
via IFTTT